This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Author: Avi Kapoor | March 25, 2025 10:57am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Morgan Stanley analyst Bob Huang downgraded the rating for Brown & Brown, Inc. (NYSE:BRO) from Overweight to Equal-Weight and maintained the price target of $128. Brown & Brown shares closed at $120.98 on Monday. See how other analysts view this stock.
- Jefferies analyst Surinder Thind downgraded Dun & Bradstreet Holdings, Inc. (NYSE:DNB) from Buy to Hold and cut the price target from $11 to $9.15. Dun & Bradstreet shares closed at $8.99 on Monday. See how other analysts view this stock.
- Leerink Partners analyst Marc Goodman downgraded Opthea Limited (NASDAQ:OPT) from Outperform to Market Perform and lowered the price target from $12 to $1. Opthea shares closed at $3.36 on Monday. See how other analysts view this stock.
- Citigroup analyst Anthony Pettinari downgraded the rating for The AZEK Company Inc. (NYSE:AZEK) from Buy to Neutral and lowered the price target from $61 to $51.5. AZEK shares closed at $48.56 on Monday. See how other analysts view this stock.
- Stephens & Co. analyst Mason Carrico downgraded Akoya Biosciences, Inc. (NASDAQ:AKYA) from Overweight to Equal-Weight and slashed the price target from $3.5 to $1.8. Akoya Biosciences shares closed at $1.67 on Monday. See how other analysts view this stock.
Considering buying BRO stock? Here’s what analysts think:
Read This Next:
Posted In: AKYA AZEK BRO DNB OPT
